Cationic lipid gene transfer of an IL-2 transgene leads to activation of natural killer cells in a SCID mouse human tumor xenograft

被引:10
作者
Clark, PR [1 ]
Stopeck, AT
Parker, SE
Hersh, EM
机构
[1] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA
[2] Vical Inc, San Diego, CA 92121 USA
关键词
interleukin-2; cationic lipid; intratumoral; natural killer cell; granzyme A; tumor;
D O I
10.1006/cimm.2000.1699
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Natural killer (NR) cells play an important role in combating infectious and malignant diseases and interleukin-2 (IL-2) has been shown to promote proliferation and activation of Mt cells in vitro and in vivo, Here we investigate the effects of local cationic lipid-mediated IL-2 gene transfer on intratumoral accumulation and activation of NK cells in a SCID mouse tumor model. UM449 human melanoma tumors in SCID mice received intratumoral injections of DMRIE/ DOPE admired with VR1103, a DNA plasmid encoding the gene for human IL-2. Dissagregated tumor cells were tested for IL-2 secretion and were characterized using antibodies to asGM1, MAC-I, and F4/80 antigens, Granzyme A, a proteolytic serine esterase, was also measured in tumor cell lysates, IL-2 secretion from tumors injected with VR1103:DMRIE/DOPE peaked at 48 h after injection and fell to baseline levels on day 8, Intratumoral granzyme A activity was significantly increased in tumors injected with IL-2 plasmid:DMRIE/DOPE complexes, but not by an irrelevant plasmid DNA:DMRIE/DOPE control. Importantly, the growth of UM449 tumors was slowed in VR1103:DMRLE/DOPE-injected tumors, These results indicate that local cationic lipid-mediated gene transfer of IL-2 induces activation of intratumoral NK cells and slows tumor growth. (C) 2000 Academic Press.
引用
收藏
页码:96 / 104
页数:9
相关论文
共 46 条
[1]   ANTITUMOR RESPONSE INDEPENDENT OF FUNCTIONAL B-LYMPHOCYTES OR T-LYMPHOCYTES INDUCED BY THE LOCAL AND SUSTAINED-RELEASE OF INTERLEUKIN-2 BY THE TUMOR-CELLS [J].
ALOSCO, T ;
CROY, BA ;
GANSBACHER, B ;
WANG, HQ ;
RAO, U ;
BANKERT, R .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (06) :364-372
[2]   F4-80, A MONOCLONAL-ANTIBODY DIRECTED SPECIFICALLY AGAINST THE MOUSE MACROPHAGE [J].
AUSTYN, JM ;
GORDON, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (10) :805-815
[3]   ACCUMULATION OF ADOPTIVELY TRANSFERRED ADHERENT, LYMPHOKINE-ACTIVATED KILLER-CELLS IN MURINE METASTASES [J].
BASSE, P ;
HERBERMAN, RB ;
NANNMARK, U ;
JOHANSSON, BR ;
HOKLAND, M ;
WASSERMAN, K ;
GOLDFARB, RH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (02) :479-488
[4]   Trafficking of activated lymphocytes into the RENCA tumour microcirculation in vivo in mice [J].
Brown, NJ ;
Ali, S ;
Reed, MWR ;
Wiltrout, R ;
Rees, RC .
BRITISH JOURNAL OF CANCER, 1997, 76 (12) :1572-1578
[5]  
CORDIER L, 1995, GENE THER, V2, P16
[6]   INTRATUMORAL INTERLEUKIN-2 IMMUNOTHERAPY - ACTIVATION OF TUMOR-INFILTRATING AND SPLENIC LYMPHOCYTES INVIVO [J].
DUBINETT, SM ;
PATRONE, L ;
TOBIAS, J ;
COCHRAN, AJ ;
WEN, DR ;
MCBRIDE, WH .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (03) :156-162
[7]  
ECONOMOU JS, 1989, IMMUNOLOGY, V67, P514
[8]  
Egilmez NK, 1996, GENE THER, V3, P607
[9]   Cytokine immunotherapy of cancer with controlled release biodegradable microspheres in a human tumor xenograft SCID mouse model [J].
Egilmez, NK ;
Jong, YS ;
Iwanuma, Y ;
Jacob, JS ;
Santos, CA ;
Chen, FA ;
Mathiowitz, E ;
Bankert, RB .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 46 (01) :21-24
[10]  
FELGNER JH, 1994, J BIOL CHEM, V269, P2550